Concepedia

Irfan Vaziri

IV

9

Publications

1K

Citations

9

H-Index

2001

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

University of Nebraska Medical Center

Nebraska Cancer Research Center

Avera Health

Puma Biotechnology (United States)

Irfan Vaziri is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and lung cancer.

Top concepts

Publications per year

2001–2020

9

Publications

9

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Miguel Martín, Frankie A. Holmes, Bent Ejlertsen et al. · The Lancet Oncology · 2017 · 578 citations

, , +10

Risk Factors for<i>Candida tropicalis</i>Fungemia in Patients with Cancer

Dimitrios P. Kontoyiannis, Irfan Vaziri, Hend Hanna et al. · Clinical Infectious Diseases · 2001 · 145 citations · Full text

Improved tolerability of neratinib in patients with HER2-positive early-stage breast cancer: the CONTROL trial

CH Barcenas, Sara A. Hurvitz, Jack A. Di Palma et al. · Annals of Oncology · 2020 · 102 citations · Full text

Patient preferences of chemotherapy treatment options and tolerance of chemotherapy side effects in advanced stage lung cancer

KM Monirul Islam, Trisari Anggondowati, Poppy E. Deviany et al. · BMC Cancer · 2019 · 90 citations · Full text

Survival data and prognostic factors seen in Pakistani patients with esophageal cancer

Amyn Alidina, Firasat Hussain, Md. Mahmudul Islam et al. · Annals of Oncology · 2003 · 52 citations · Full text

, , +8

Rows per page

1–5 of 9